Valuation: Imexpharm Corporation

Market Cap 5,745B 219M 188M 176M 161M 303M 20.97B 308M 2.07B 812M 10.52B 824M 806M 34.77B P/E 2026 *
16.2x
P/E 2027 * 14.9x
Enterprise Value 5,745B 219M 188M 176M 161M 303M 20.97B 308M 2.07B 812M 10.52B 824M 806M 34.77B EV / Sales 2026 *
2.16x
EV / Sales 2027 * 1.99x
Free-Float
6.42%
Yield 2026 *
2.68%
Yield 2027 * 2.68%
1 day+0.54%
1 week+0.27%
Current month+6.27%
1 month-4.60%
3 months-19.35%
6 months-30.15%
Current year-28.95%
1 week 35,900
Extreme 35900
40,050
1 month 32,650
Extreme 32650
40,050
Current year 32,650
Extreme 32650
57,000
1 year 32,650
Extreme 32650
57,000
3 years 23,681.82
Extreme 23681.818181
57,000
5 years 18,831.17
Extreme 18831.168829
57,000
10 years 13,036.96
Extreme 13036.963036
57,000
Manager TitleAgeSince
Chief Executive Officer 74 31/07/2001
Director of Finance/CFO 52 17/01/2024
Chief Operating Officer 47 -
Director TitleAgeSince
Chairman 74 31/12/1983
Director/Board Member 50 27/04/2018
Director/Board Member - 29/05/2020
Date Insider Type Main position Quantity % Market Cap.
26/09/22 Buy

Chief Executive Officer

140,000 0.2100%
20/07/22 Sell

Chief Executive Officer

100,000 0.1500%
01/04/22 Fiscal year

Chairman

50,000 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+0.54%+0.27%-32.06%+26.71% 218M
+3.46%+3.99%+80.45%+130.70% 1,093B
+0.73%+4.56%+53.40%+62.98% 653B
+1.89%+5.84%+27.70%+75.34% 458B
+1.80%+0.52%+41.20%+44.48% 355B
+1.24%+2.35%+25.99%+41.24% 294B
+2.07%+2.97%+2.27%+12.89% 248B
+3.23%+5.34%+48.33%+68.16% 230B
+1.05%-0.02%-13.96%-52.51% 203B
+2.84%+8.54%+25.00%+94.19% 178B
Average +1.85%+0.99%+25.83%+50.42% 371.07B
Weighted average by Cap. +2.15%+1.45%+46.08%+73.11%

Financials

2026 *2027 *
Net sales 2,659B 102M 87.11M 81.34M 74.63M 140M 9.71B 143M 960M 376M 4.87B 381M 373M 16.1B 2,881B 110M 94.38M 88.13M 80.86M 152M 10.52B 155M 1.04B 407M 5.27B 413M 404M 17.44B
Net income 394B 15.05M 12.91M 12.05M 11.06M 20.79M 1.44B 21.14M 142M 55.69M 721M 56.5M 55.27M 2.38B 428B 16.35M 14.02M 13.09M 12.01M 22.59M 1.56B 22.96M 154M 60.5M 784M 61.38M 60.04M 2.59B
Net Debt - -
Logo Imexpharm Corporation
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Employees
1,438
Date Price Change Volume
18/08/26 37,300.00 +0.54% 11,165
18/08/26 ₫37,100.00 +0.82% 11,946
17/08/26 ₫36,800.00 -0.81% 3,337
14/08/26 ₫37,100.00 -1.46% 15,001
13/08/26 ₫37,650.00 +0.40% 43,495
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
37,300.00VND
Average target price
56,000.00VND
Spread / Average Target
+50.13%

Annual profits - Rate of surprise